551 related articles for article (PubMed ID: 24131709)
1. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.
Hawman DW; Stoermer KA; Montgomery SA; Pal P; Oko L; Diamond MS; Morrison TE
J Virol; 2013 Dec; 87(24):13878-88. PubMed ID: 24131709
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya Virus Evades Antiviral CD8
Davenport BJ; Bullock C; McCarthy MK; Hawman DW; Murphy KM; Kedl RM; Diamond MS; Morrison TE
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102875
[TBL] [Abstract][Full Text] [Related]
3. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.
Dupuis-Maguiraga L; Noret M; Brun S; Le Grand R; Gras G; Roques P
PLoS Negl Trop Dis; 2012; 6(3):e1446. PubMed ID: 22479654
[TBL] [Abstract][Full Text] [Related]
4. A high-dose inoculum size results in persistent viral infection and arthritis in mice infected with chikungunya virus.
Zhang Y; Yan H; Li X; Zhou D; Zhong M; Yang J; Zhao B; Fan X; Fan J; Shu J; Lu M; Jin X; Zhang E; Yan H
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010149. PubMed ID: 35100271
[TBL] [Abstract][Full Text] [Related]
5. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
[TBL] [Abstract][Full Text] [Related]
6. Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.
Hong JP; McCarthy MK; Davenport BJ; Morrison TE; Diamond MS
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578287
[TBL] [Abstract][Full Text] [Related]
7. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
8. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.
Messaoudi I; Vomaske J; Totonchy T; Kreklywich CN; Haberthur K; Springgay L; Brien JD; Diamond MS; Defilippis VR; Streblow DN
PLoS Negl Trop Dis; 2013; 7(7):e2343. PubMed ID: 23936572
[TBL] [Abstract][Full Text] [Related]
9. A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.
Seymour RL; Adams AP; Leal G; Alcorn MD; Weaver SC
PLoS Negl Trop Dis; 2015; 9(6):e0003800. PubMed ID: 26115459
[TBL] [Abstract][Full Text] [Related]
10. A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice.
Teo TH; Lum FM; Claser C; Lulla V; Lulla A; Merits A; Rénia L; Ng LF
J Immunol; 2013 Jan; 190(1):259-69. PubMed ID: 23209328
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.
Gardner CL; Burke CW; Higgs ST; Klimstra WB; Ryman KD
Virology; 2012 Apr; 425(2):103-12. PubMed ID: 22305131
[TBL] [Abstract][Full Text] [Related]
12. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.
Teo TH; Her Z; Tan JJ; Lum FM; Lee WW; Chan YH; Ong RY; Kam YW; Leparc-Goffart I; Gallian P; Rénia L; de Lamballerie X; Ng LF
J Virol; 2015 Aug; 89(15):7955-69. PubMed ID: 25995257
[TBL] [Abstract][Full Text] [Related]
13. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.
Morrison TE; Oko L; Montgomery SA; Whitmore AC; Lotstein AR; Gunn BM; Elmore SA; Heise MT
Am J Pathol; 2011 Jan; 178(1):32-40. PubMed ID: 21224040
[TBL] [Abstract][Full Text] [Related]
14. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response.
Hoarau JJ; Jaffar Bandjee MC; Krejbich Trotot P; Das T; Li-Pat-Yuen G; Dassa B; Denizot M; Guichard E; Ribera A; Henni T; Tallet F; Moiton MP; Gauzère BA; Bruniquet S; Jaffar Bandjee Z; Morbidelli P; Martigny G; Jolivet M; Gay F; Grandadam M; Tolou H; Vieillard V; Debré P; Autran B; Gasque P
J Immunol; 2010 May; 184(10):5914-27. PubMed ID: 20404278
[TBL] [Abstract][Full Text] [Related]
15. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
Amdekar S; Parashar D; Alagarasu K
Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
[TBL] [Abstract][Full Text] [Related]
16. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
[TBL] [Abstract][Full Text] [Related]
17. Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA.
Young AR; Locke MC; Cook LE; Hiller BE; Zhang R; Hedberg ML; Monte KJ; Veis DJ; Diamond MS; Lenschow DJ
PLoS Pathog; 2019 Aug; 15(8):e1007993. PubMed ID: 31465513
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.
Chu H; Das SC; Fuchs JF; Suresh M; Weaver SC; Stinchcomb DT; Partidos CD; Osorio JE
Vaccine; 2013 Jul; 31(33):3353-60. PubMed ID: 23727003
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.
Lum FM; Couderc T; Chia BS; Ong RY; Her Z; Chow A; Leo YS; Kam YW; Rénia L; Lecuit M; Ng LFP
Sci Rep; 2018 Jan; 8(1):1860. PubMed ID: 29382880
[TBL] [Abstract][Full Text] [Related]
20. Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.
Locke MC; Fox LE; Dunlap BF; Young AR; Monte K; Lenschow DJ
J Virol; 2022 Jan; 96(1):e0114321. PubMed ID: 34668781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
